Journals shouldn't accept ads: article

Share this article:
An article in PLoS Medicine called for medical journals to reject ads from drug companies, saying they compromise the objectivity of journals.

The article, co-authored by Georgetown University Medical Center professor and HRT critic Adriane Fugh-Berman, examined ads in nine medical journals, concluding they were “unreliable sources of information, since they ‘educate' physicians to prescribe the newest, most expensive drugs (which may not be superior to existing, less expensive alternatives).” Publishers could replace the lost income with consumer products advertising, the authors said. 

PLoS Medicine, a nonprofit, does not accept drug ads.

Share this article:
close

Next Article in News

Email Newsletters

More in News

House bill would speed approval once EU OKs same product

House bill would speed approval once EU OKs ...

The Speeding Access to Already Approved Pharmaceuticals Act of 2014 would require FDA to expedite the review of pharmaceuticals that are already approved by the European Union

Rep access continues to shrink

Rep access continues to shrink

Sales reps are experiencing even more limited physician access, according to a report by Chicago consultancy ZS Associates.

Allergan touts reorg, plans to lay off 13% of workforce

Allergan touts reorg, plans to lay off 13% ...

Allergan's second-quarter earnings, and a new round of cuts, are now part of the Botox maker's record as it seeks to remain independent.